PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
16140980-0	2005	Mechanism of action of (-)-epigallocatechin-3-gallate: auto-oxidation-dependent inactivation of epidermal growth factor receptor and direct effects on growth inhibition in human esophageal cancer KYSE 150 cells.	epigallocatechin gallate	23-53	epidermal growth factor receptor	Homo sapiens	96-128	
16140980-1	2005	(-)-Epigallocatechin-3-gallate (EGCG), the principal polyphenol in green tea, has been shown to inhibit the growth of many cancer cell lines and to suppress the phosphorylation of epidermal growth factor receptor (EGFR).	epigallocatechin gallate	0-30	epidermal growth factor receptor	Homo sapiens	180-212	
16140980-1	2005	(-)-Epigallocatechin-3-gallate (EGCG), the principal polyphenol in green tea, has been shown to inhibit the growth of many cancer cell lines and to suppress the phosphorylation of epidermal growth factor receptor (EGFR).	epigallocatechin gallate	0-30	epidermal growth factor receptor	Homo sapiens	214-218	
16140980-1	2005	(-)-Epigallocatechin-3-gallate (EGCG), the principal polyphenol in green tea, has been shown to inhibit the growth of many cancer cell lines and to suppress the phosphorylation of epidermal growth factor receptor (EGFR).	epigallocatechin gallate	32-36	epidermal growth factor receptor	Homo sapiens	180-212	
16140980-1	2005	(-)-Epigallocatechin-3-gallate (EGCG), the principal polyphenol in green tea, has been shown to inhibit the growth of many cancer cell lines and to suppress the phosphorylation of epidermal growth factor receptor (EGFR).	epigallocatechin gallate	32-36	epidermal growth factor receptor	Homo sapiens	214-218	
16140980-3	2005	Pretreatment of KYSE 150 cells with EGCG (20 micromol/L) for 0.5 to 24 hours in HAM"s F12 and RPMI 1640 mixed medium at 37 degrees C, before the addition of EGF, resulted in a decreased level of phosphorylated EGFR (by 32-85%).	epigallocatechin gallate	36-40	epidermal growth factor receptor	Homo sapiens	210-214	
16140980-4	2005	Prolonged treatment with EGCG (8 or 24 hours) also decreased EGFR protein level (both by 80%).	epigallocatechin gallate	25-29	epidermal growth factor receptor	Homo sapiens	61-65	
16140980-12	2005	The results suggest that in cell culture conditions, the auto-oxidation of EGCG leads to EGFR inactivation, but the inhibition of cell growth is due to other mechanisms.	epigallocatechin gallate	75-79	epidermal growth factor receptor	Homo sapiens	89-93